NPC1L1 and pancreatic adenocarcinoma: Their results indicated that the ectopic expression of NPC1L1 in Pancreatic Adenocarcinoma (PAAD) cells inhibited the activation and proliferation of anti-tumor CD8+ T cells within the tumor microenvironment.